Pentoxifylline, a methylxanthine drug that acts as a strong non-selective TNF-α inhibitor, has improved depressive behavior in animal models but has also shown positive results as an add-on treatment for depression [126,127,128]. This evidence concerns the gene TNF and depressive symptom measurement.